Picture of Immuneering logo

IMRX — Immuneering News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Immuneering Reports Third Quarter Results

Nov 10 (Reuters) - Immuneering Corp  IMRX.O :
    * IMMUNEERING REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
    * Q3 LOSS PER SHARE $0.49
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF
$117.2M AT
QUARTER END, EXPECTED TO PROVIDE CASH RUNWAY INTO Q3 2024
    * Q3 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbNJXJ7 
Further company coverage:  IMRX.O 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on Immuneering

See all news